Oesterle Stephen N. 4
4 · Sigilon Therapeutics, Inc. · Filed Dec 7, 2020
Insider Transaction Report
Form 4
OESTERLE STEPHEN N
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-03+8,888→ 8,888 totalExercise: $18.00Exp: 2030-12-02→ Common Stock (8,888 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on the earlier of July 14, 2021 or the Company's next annual meeting of stockholders.